Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum

Background: The impact of pregnancy on efavirenz (EFV) pharmacokinetics is unknown. Methods: International Maternal Pediatric Adolescent AIDS Clinical Trials P1026s is an on-going, prospective, nonblinded study of antiretroviral pharmacokinetics in HIV-infected pregnant women that included a cohort...

Saved in:

書目詳細資料
Main Authors:	Tim R. Cressey, Alice Stek, Edmund Capparelli, Chureeratana Bowonwatanuwong, Sinart Prommas, Pannee Sirivatanapa, Prapap Yuthavisuthi, Chanon Neungton, Yanling Huo, Elizabeth Smith, Brookie M. Best, Mark Mirochnick
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84859758788&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51935
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Cressey T., et al.
出版: (2017)

Efavirenz pharmacokinetics during pregnancy and infant washout
由: Regis Kreitchmann, et al.
出版: (2019)

Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
由: Tim R. Cressey, et al.
出版: (2018)

Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
由: Tim R. Cressey, et al.
出版: (2018)

Reduced indinavir exposure during pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Reduced indinavir exposure during pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
由: Regis Kreitchmann, et al.
出版: (2018)

Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
由: Regis Kreitchmann, et al.
出版: (2018)

Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
由: Cressey T.R., et al.
出版: (2014)

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
由: Stein Schalkwijk, et al.
出版: (2018)

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
由: Stein Schalkwijk, et al.
出版: (2018)

Does pregnancy affect the pharmacokinetics of efavirenz?
由: Andrew Hill, et al.
出版: (2018)

Does pregnancy affect the pharmacokinetics of efavirenz?
由: Andrew Hill, et al.
出版: (2018)

Does pregnancy affect the pharmacokinetics of efavirenz?
由: Hill A., et al.
出版: (2014)

Single dose cefazolin for abdominal hysterectomy prophylaxis
由: Sinart Prommas
出版: (2009)

Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
由: Bouazza N., et al.
出版: (2017)

Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women
由: Alice Stek, et al.
出版: (2018)

Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women
由: Alice Stek, et al.
出版: (2018)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
由: Naïm Bouazza, et al.
出版: (2018)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients
由: Naïm Bouazza, et al.
出版: (2018)

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial
由: Esaú C. João, et al.
出版: (2020)

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Efavirenz concentrations and probability of HIV replication in children
由: Nontiya Homkham, et al.
出版: (2018)

Efavirenz concentrations and probability of HIV replication in children
由: Nontiya Homkham, et al.
出版: (2018)

Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
由: Cressey T., et al.
出版: (2017)

Raltegravir pharmacokinetics during pregnancy
由: D. Heather Watts, et al.
出版: (2018)

Raltegravir pharmacokinetics during pregnancy
由: D. Heather Watts, et al.
出版: (2018)

Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits
由: Gornganok Piboonpol
出版: (2013)

KINETICS STUDY IN EFAVIRENZ POLYMORPHIC TRANSFORMATION
由: Windhu Wardhana, Yoga

Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism
由: C. Sukasem, et al.
出版: (2018)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
由: Risa M. Hoffman, et al.
出版: (2020)

High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections
由: Chonlaphat Sukasem, et al.
出版: (2018)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
由: Cressey T.R., et al.
出版: (2014)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
由: Tim R. Cressey, et al.
出版: (2018)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
由: Tim R. Cressey, et al.
出版: (2018)

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children
由: Tim R. Cressey, et al.
出版: (2018)

Pre-operative prediction of serum CA125 level in women with ovarian masses
由: Mongkol Benjapibal, et al.
出版: (2018)

Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai Children
由: Puthanakit T., et al.
出版: (2014)